Genome-wide association study on immunoglobulin G glycosylation patterns

Frontiers in Immunology

Volumn 9, Issue FEB, 2018, Pages

  Wahl, Annika ^a   van den Akker, Erik ^b,c   Klaric, Lucija ^d,e,f   Štambuk, Jerko ^d   Benedetti, Elisa ^a   Plomp, Rosina ^b   Razdorov, Genadij ^d   Trbojević Akmačić, Irena ^d   Deelen, Joris ^b,g   van Heemst, Diana ^b   Eline Slagboom, P ^b   Vučković, Frano ^d   Grallert, Harald ^a,h   Krumsiek, Jan ^a,h   Strauch, Konstantin ^a,i   Peters, Annette ^a   Meitinger, Thomas ^a   Hayward, Caroline ^e   Wuhrer, Manfred ^b   Beekman, Marian ^b   Lauc, Gordan ^d,j   Gieger, Christian ^a   more..

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

^d GENOS GLYCOSCIENCE RESEARCH LABORATORY   (Croatia)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g MAX PLANCK INSTITUTE FOR BIOLOGY OF AGEING   (Germany)

^h GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

ⁱ UNIVERSITY OF MUNICH   (Germany)

^j UNIVERSITY OF ZAGREB   (Croatia)

more..

Author keywords

Genome wide association study; Glycosylation; Immunoglobulin G; LC ESI MS; RUNX3

Indexed keywords

GLYCOSYLTRANSFERASE; IMMUNOGLOBULIN G; SIALYLTRANSFERASE; TRANSCRIPTION FACTOR RUNX3;

ADULT; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; COHORT ANALYSIS; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GLYCOSYLATION; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; PHENOTYPE; PROTEIN PURIFICATION; SINGLE NUCLEOTIDE POLYMORPHISM; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 85042537258     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2018.00277     Document Type: Article

References (66)

1. Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol (2007) 25:21-50. doi:10.1146/annurev.immunol.25.022106.141702
2. Trbojevic Akmacic I, Ventham NT, Theodoratou E, Vuckovic F, Kennedy NA, Kristic J, et al. Inflammatory bowel disease associates with proinflammatory potential of the immunoglobulin G glycome. Inflamm Bowel Dis (2015) 21(6):1237-47. doi:10.1097/MIB.0000000000000372
3. Barrios C, Zierer J, Gudelj I, Stambuk J, Ugrina I, Rodriguez E, et al. Glycosylation profile of IgG in moderate kidney dysfunction. J Am Soc Nephrol (2016) 27(3):933-41. doi:10.1681/ASN.2015010109
4. Wiederschain G. Introduction to Glycobiology and Human Diseases. CRC Press (2016). p. 1-27. doi:10.1201/b20120-2
5. Zhang D, Chen B, Wang Y, Xia P, He C, Liu Y, et al. Disease-specific IgG Fc N-glycosylation as personalized biomarkers to differentiate gastric cancer from benign gastric diseases. Sci Rep (2016) 6:25957. doi:10.1038/srep25957
6. Sethi MK, Hancock WS, Fanayan S. Identifying N-glycan biomarkers in colorectal cancer by mass spectrometry. Acc Chem Res (2016) 49(10):2099-106. doi:10.1021/acs.accounts.6b00193
7. Ruhaak LR, Kim K, Stroble C, Taylor SL, Hong Q, Miyamoto S, et al. Protein-specific differential glycosylation of immunoglobulins in serum of ovarian cancer patients. J Proteome Res (2016) 15(3):1002-10. doi:10.1021/acs.jproteome.5b01071
8. Lemjabbar-Alaoui H, McKinney A, Yang YW, Tran VM, Phillips JJ. Glycosylation alterations in lung and brain cancer. Adv Cancer Res (2015) 126:305-44. doi:10.1016/bs.acr.2014.11.007
9. Mehta A, Herrera H, Block T. Glycosylation and liver cancer. Adv Cancer Res (2015) 126:257-79. doi:10.1016/bs.acr.2014.11.005
10. Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer (2015) 15(9):540-55. doi:10.1038/nrc3982
11. Taniguchi N, Kizuka Y. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics. Adv Cancer Res (2015) 126:11-51. doi:10.1016/bs.acr.2014.11.001
12. Chen G, Wang Y, Qiu L, Qin X, Liu H, Wang X, et al. Human IgG Fc-glycosylation profiling reveals associations with age, sex, female sex hormones and thyroid cancer. J Proteomics (2012) 75(10):2824-34. doi:10.1016/j.jprot.2012.02.001
13. Kizuka Y, Taniguchi N. Enzymes for N-glycan branching and their genetic and nongenetic regulation in cancer. Biomolecules (2016) 6(2):E25. doi:10.3390/biom6020025
14. Menni C, Keser T, Mangino M, Bell JT, Erte I, Akmacic I, et al. Glycosylation of immunoglobulin g: role of genetic and epigenetic influences. PLoS One (2013) 8(12):e82558. doi:10.1371/journal.pone.0082558
15. Maratha A, Stockmann H, Coss KP, Estela Rubio-Gozalbo M, Knerr I, Fitzgibbon M, et al. Classical galactosaemia: novel insights in IgG N-glycosylation and N-glycan biosynthesis. Eur J Hum Genet (2016) 24(7):976-84. doi:10.1038/ejhg.2015.254
16. Taniguchi N. Glycoscience: Biology and Medicine. Japan: Springer (2015)
17. Hamilton RG. In: Mohan C, editor. The Human IgG Subclasses. Baltimore, MD: Calbiochem-Novabiochem Corporation (2001)
18. Marth JD, Grewal PK. Mammalian glycosylation in immunity. Nat Rev Immunol (2008) 8(11):874-87. doi:10.1038/nri2417
19. Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stanworth D, et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature (1985) 316(6027):452-7. doi:10.1038/316452a0
20. Pucic M, Knezevic A, Vidic J, Adamczyk B, Novokmet M, Polasek O, et al. High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol Cell Proteomics (2011) 10(10):M111010090. doi:10.1074/mcp.M111.010090
21. Lauc G, Huffman JE, Pucic M, Zgaga L, Adamczyk B, Muzinic A, et al. Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers. PLoS Genet (2013) 9(1):e1003225. doi:10.1371/journal.pgen.1003225
22. Schoenmaker M, de Craen AJ, de Meijer PH, Beekman M, Blauw GJ, Slagboom PE, et al. Evidence of genetic enrichment for exceptional survival using a family approach: the Leiden Longevity Study. Eur J Hum Genet (2006) 14(1):79-84. doi:10.1038/sj.ejhg.5201508
23. Shen X, Klaric L, Sharapov S, Mangino M, Ning Z, Wu D, et al. Multivariate discovery and replication of five novel loci associated with Immunoglobulin G N-glycosylation. Nat Commun (2017) 8(1):447. doi:10.1038/s41467-017-00453-3
24. Huffman JE, Pucic-Bakovic M, Klaric L, Hennig R, Selman MH, Vuckovic F, et al. Comparative performance of four methods for high-throughput glycosylation analysis of immunoglobulin G in genetic and epidemiological research. Mol Cell Proteomics (2014) 13(6):1598-610. doi:10.1074/mcp.M113.037465
25. Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol (2014) 5:520. doi:10.3389/fimmu.2014.00520
26. Wuhrer M, Stam JC, van de Geijn FE, Koeleman CA, Verrips CT, Dolhain RJ, et al. Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum. Proteomics (2007) 7(22):4070-81. doi:10.1002/pmic.200700289
27. Petersen AK, Krumsiek J, Wagele B, Theis FJ, Wichmann HE, Gieger C, et al. On the hypothesis-free testing of metabolite ratios in genome-wide and metabolome-wide association studies. BMC Bioinformatics (2012) 13:120. doi:10.1186/1471-2105-13-120
28. Benedetti E, Pucic-Bakovic M, Keser T, Wahl A, Hassinen A, Yang JY, et al. Network inference from glycoproteomics data reveals new reactions in the IgG glycosylation pathway. Nat Commun (2017) 8(1):1483. doi:10.1038/s41467-017-01525-0
29. Voon DC, Hor YT, Ito Y. The RUNX complex: reaching beyond haematopoiesis into immunity. Immunology (2015) 146(4):523-36. doi:10.1111/imm.12535
30. He SY, Jiang RF, Jiang J, Xiang YS, Wang L. Investigation of methylation and protein expression of the Runx3 gene in colon carcinogenesis. Biomed Rep (2015) 3(5):687-90. doi:10.3892/br.2015.479
31. Estecio MR, Maddipoti S, Bueso-Ramos C, DiNardo CD, Yang H, Wei Y, et al. RUNX3 promoter hypermethylation is frequent in leukaemia cell lines and associated with acute myeloid leukaemia inv(16) subtype. Br J Haematol (2015) 169(3):344-51. doi:10.1111/bjh.13299
32. Zhang X, He H, Zhang X, Guo W, Wang Y. RUNX3 promoter methylation is associated with hepatocellular carcinoma risk: a meta-analysis. Cancer Invest (2015) 33(4):121-5. doi:10.3109/07357907.2014.1003934
33. Lotem J, Levanon D, Negreanu V, Bauer O, Hantisteanu S, Dicken J, et al. Runx3 at the interface of immunity, inflammation and cancer. Biochim Biophys Acta (2015) 1855(2):131-43. doi:10.1016/j.bbcan.2015.01.004
34. Hor YT, Voon DC, Koo JK, Wang H, Lau WM, Ashktorab H, et al. A role for RUNX3 in inflammation-induced expression of IL23A in gastric epithelial cells. Cell Rep (2014) 8(1):50-8. doi:10.1016/j.celrep.2014.06.003
35. Tserel L, Kolde R, Limbach M, Tretyakov K, Kasela S, Kisand K, et al. Age-related profiling of DNA methylation in CD8+ T cells reveals changes in immune response and transcriptional regulator genes. Sci Rep (2015) 5:13107. doi:10.1038/srep13107
36. Whiteman HJ, Farrell PJ. RUNX expression and function in human B cells. Crit Rev Eukaryot Gene Expr (2006) 16(1):31-44. doi:10.1615/CritRevEukarGeneExpr.v16.i1.30
37. Chen F, Liu X, Bai J, Pei D, Zheng J. The emerging role of RUNX3 in cancer metastasis (Review). Oncol Rep (2016) 35(3):1227-36. doi:10.3892/or.2015.4515
38. Steinke FC, Yu S, Zhou X, He B, Yang W, Zhou B, et al. TCF-1 and LEF-1 act upstream of Th-POK to promote the CD4(+) T cell fate and interact with Runx3 to silence Cd4 in CD8(+) T cells. Nat Immunol (2014) 15(7):646-56. doi:10.1038/ni.2897
39. Mookerjee-Basu J, Kappes DJ. New ingredients for brewing CD4(+)T (cells): TCF-1 and LEF-1. Nat Immunol (2014) 15(7):593-4. doi:10.1038/ni.2927
40. Overgaard NH, Jung JW, Steptoe RJ, Wells JW. CD4+/CD8+ double-positive T cells: more than just a developmental stage? J Leukoc Biol (2015) 97(1):31-8. doi:10.1189/jlb.1RU0814-382
41. Xiong Y, Castro E, Yagi R, Zhu J, Lesourne R, Love PE, et al. Thpok-independent repression of Runx3 by Gata3 during CD4+ T-cell differentiation in the thymus. Eur J Immunol (2013) 43(4):918-28. doi:10.1002/eji.201242944
42. Wang J, Balog CI, Stavenhagen K, Koeleman CA, Scherer HU, Selman MH, et al. Fc-glycosylation of IgG1 is modulated by B-cell stimuli. Mol Cell Proteomics (2011) 10(5):M110004655. doi:10.1074/mcp.M110.004655
43. Harker N, Naito T, Cortes M, Hostert A, Hirschberg S, Tolaini M, et al. The CD8alpha gene locus is regulated by the Ikaros family of proteins. Mol Cell (2002) 10(6):1403-15. doi:10.1016/S1097-2765(02)00711-6
44. Prasad RB, Hosking FJ, Vijayakrishnan J, Papaemmanuil E, Koehler R, Greaves M, et al. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood (2010) 115(9):1765-7. doi:10.1182/blood-2009-09-241513
45. Balbin M, Grubb A, de Lange GG, Grubb R. DNA sequences specific for caucasian G3m(b) and (g) allotypes: allotyping at the genomic level. Immunogenetics (1994) 39(3):187-93. doi:10.1007/BF00241259
46. Abes R, Teillaud JL. Impact of glycosylation on effector functions of therapeutic IgG. Pharmaceuticals (Basel) (2010) 3(1):146-57. doi:10.3390/ph3010146
47. Dorokhov YL, Sheshukova EV, Kosobokova EN, Shindyapina AV, Kosorukov VS, Komarova TV. Functional role of carbohydrate residues in human immunoglobulin G and therapeutic monoclonal antibodies. Biochemistry (Mosc) (2016) 81(8):835-57. doi:10.1134/S0006297916080058
48. Irani V, Guy AJ, Andrew D, Beeson JG, Ramsland PA, Richards JS. Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases. Mol Immunol (2015) 67(2 Pt A):171-82. doi:10.1016/j.molimm.2015.03.255
49. Mimura Y, Katoh T, Saldova R, O'Flaherty R, Izumi T, Mimura-Kimura Y, et al. Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy. Protein Cell (2017) 9(1):47-62. doi:10.1007/s13238-017-0433-3
50. Reusch D, Tejada ML. Fc glycans of therapeutic antibodies as critical quality attributes. Glycobiology (2015) 25(12):1325-34. doi:10.1093/glycob/cwv065
51. Wichmann HE, Gieger C, Illig T, Group MKS. KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen (2005) 67(Suppl 1):S26-30. doi:10.1055/s-2005-858226
52. Holle R, Happich M, Lowel H, Wichmann HE, Group MKS. KORA-a research platform for population based health research. Gesundheitswesen (2005) 67(Suppl 1):S19-25. doi:10.1055/s-2005-858235
53. Livshits G, Macgregor AJ, Gieger C, Malkin I, Moayyeri A, Grallert H, et al. An omics investigation into chronic widespread musculoskeletal pain reveals epiandrosterone sulfate as a potential biomarker. Pain (2015) 156(10):1845-51. doi:10.1097/j.pain.0000000000000200
54. Ha NT, Freytag S, Bickeboeller H. Coverage and efficiency in current SNP chips. Eur J Hum Genet (2014) 22(9):1124-30. doi:10.1038/ejhg.2013.304
55. Westendorp RG, van Heemst D, Rozing MP, Frolich M, Mooijaart SP, Blauw GJ, et al. Nonagenarian siblings and their offspring display lower risk of mortality and morbidity than sporadic nonagenarians: the Leiden Longevity Study. J Am Geriatr Soc (2009) 57(9):1634-7. doi:10.1111/j.1532-5415.2009.02381.x
56. Beekman M, Blauw GJ, Houwing-Duistermaat JJ, Brandt BW, Westendorp RG, Slagboom PE. Chromosome 4q25, microsomal transfer protein gene, and human longevity: novel data and a meta-analysis of association studies. J Gerontol A Biol Sci Med Sci (2006) 61(4):355-62. doi:10.1093/gerona/61.4.355
57. Selman MH, Derks RJ, Bondt A, Palmblad M, Schoenmaker B, Koeleman CA, et al. Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC-MS using a sheath-flow ESI sprayer interface. J Proteomics (2012) 75(4):1318-29. doi:10.1016/j.jprot.2011.11.003
58. Ugrina I, Klaric L, Vuckovic F. glycanr: Tools for Analysing N-Glycan Data (R Package Version 0.3.0.). (2016). Available from: https://cran.r-project.org/web/packages/glycanr/index.html
59. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics (2007) 8(1):118-27. doi:10.1093/biostatistics/kxj037
60. Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics (2012) 28(6):882-3. doi:10.1093/bioinformatics/bts034
61. Taniguchi N. Handbook of Glycosyltransferases and Related Genes. Springer (2014). doi:10.1007/978-4-431-54240-7
62. Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet (2007) 39(7):906-13. doi:10.1038/ng2088
63. Uh HW, Beekman M, Meulenbelt I, Houwing-Duistermaat JJ. Genotype-based score test for association testing in families. Stat Biosci (2015) 7(2):394-416. doi:10.1007/s12561-015-9128-6
64. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics (2010) 26(17):2190-1. doi:10.1093/bioinformatics/btq340
65. Arnold M, Raffler J, Pfeufer A, Suhre K, Kastenmuller G. SNiPA: an interactive, genetic variant-centered annotation browser. Bioinformatics (2015) 31(8):1334-6. doi:10.1093/bioinformatics/btu779
66. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res (2002) 12(6):996-1006. doi:10.1101/gr.229102